Head of lab and specialty chemicals portfolio (>1 Bn USD annual sales). Management responsibilities include portfolio strategy, product management, product innovation, marketing operations, technical sales specialists.

Head of Global Strategic Marketing for $2Bn+ Research business. Responsibilities include:+Leading research segment marketing, including marketing to academia, pharmaceutical, biotech customers+Global marketing prioritization and key marketing partner for Sales organization+Development of customer-led innovation for product development+Leading strategic planning, including corporate strategy process and strategic initiatives+Identifying, developing, and negotiating Strategic Alliances with key industry partners

Led multiple business integration workstreams for integration of $17 B acquisition of Sigma-Aldrich. Integration workstreams included Marketing, R&D, Commercial, and Operations.

● Lead strategic planning and strategic initiatives for Bioscience Business Unit● Lead Business Development activities for Bioscience, including identifying partners, managing partner pipeline, leading term sheet negotiation, and managing post-deal relationship● Lead M&A business case development for Bioscience, including building and prioritizing target pipeline, building business financial case, and developing proposals for high priority targets● Lead Market Insights, including competitive intelligence, market mapping (size, growth, share)● Lead Business Analytics, including overall quarterly business and portfolio reviews and in-depth analyses on selected businesses

● Lead strategic planning and strategic initiatives for Bioscience Business Unit● Support Licensing and M&A activity with product and company assessments through primary and secondary market research, financial modeling, industry and competitive scans● Conduct market analytics, including competitive intelligence, market research, industry scans for Bioscience

Strategic consulting for clients in the healthcare industry on topics ranging from corporate strategy to licensing and acquisition strategy. Prior projects have included:● Developed acquisition strategy for large pharmaceutical company; screened several hundred small-cap biotech targets resulting in 5 acquisitions totaling ~$4B over 2 years● Private equity due diligence on durable medical equipment market size and growth as part of pre-LOI assessment of a target company● Private equity due diligence on specialty pharmaceutical company, including overall market size and growth, competitive positioning of target company, and revenue projections for marketed and pipeline products● Private equity due diligence assessing revenue potential for portfolio specialty pharmaceutical company assets; assessment included pricing upside potential, and adjacent growth opportunities● Development of US commercial strategy for specialty pharmaceutical company following expected changes in healthcare reform, resulted in $10M increase in EBITDA in first year of implementation● Developed pricing strategy for top global biotech company, including contracting and negotiation positioning with health insurance organizations, resulted in $43M increase in EBITDA● Developed Risk Evaluation and Mitigation Strategy for specialty pharmaceutical company, including program design, assessment of impact through primary market research, and drafting of regulatory documents● Development of molecular diagnostics strategy for life science tools company, including market assessment and potential market entry options

Developed cell-based high throughput screening assays to study animal models of Alzheimer's Disease

Curated and quality controlled DNA sequence databases